Kristen Hege - Nov 1, 2023 Form 3 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Kristen Hege
Stock symbol
ADAP
Transactions as of
Nov 1, 2023
Transactions value $
$0
Form type
3
Date filed
11/1/2023, 05:00 PM
Previous filing
Oct 4, 2023
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADAP Option to purchase Ordinary Shares Nov 1, 2023 Ordinary Shares 1M $0.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable as to 250,000 Ordinary Shares on November 1, 2024 and will be exercisable as to the remainder in monthly installments of 31,250 Ordinary Shares on the first of each month from December 1, 2024 through November 1, 2026.
F2 The exercise price was converted from GBP0.07 based on an exchange rate of $U.S. 1.2133 to GBP1.00. The actual exercise price will be the pounds sterling amount.